A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/135 (2006.01) A61K 9/20 (2006.01) A61K 9/22 (2006.01) A61K 31/137 (2006.01)
Patent
CA 2238930
A sustained-release pharmaceutical composition comprising a highly soluble pharmaceutical agent, such as selegiline, in a pharmaceutical carrier comprising a hydrophilic polymer dispersed in a hydrophobic matrix. A hydrophilic microenvironment is created in a hydrophobic matrix by incorporating hydrophilic polymers within a hydrophobic matrix. Optionally, a binder, preferably a polyhydroyxlated compound, can also be added.
Composition pharmaceutique à libération prolongée comprenant un agent pharmaceutique hautement soluble tel que la sélégiline, dans un excipient pharmaceutique comprenant un polymère hydrophile dispersé dans une matrice hydrophobe. Un microenvironnement hydrophile est créé dans une matrice hydrophobe par incorporation de polymères hydrophiles à l'intérieur d'une matrice hydrophobe. On peut également ajouter, à titre d'option, un liant, de préférence un composé polyhydroxylé.
Belenduik George W.
Mccarty John A.
Rudnic Edward M.
Shire Laboratories Inc.
Shire Laboratories Inc.
Smart & Biggar
LandOfFree
Sustained-release drug delivery system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Sustained-release drug delivery system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sustained-release drug delivery system will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1935274